Will Actinogen Ace Alzheimer's?
Alzheimer’s disease is an incurable neurodegenerative disorder that robs the affected individuals of memory, self-care and quality of life,...
304 Views
The Week That Was in NorthAsia@Smartkarma: Japan Technical Bulls, Sosei & Jin Air/CTK Cosmetics IPOs
With earnings season coming to a close, content was lighter this week in Japan and Korea. Douglas and Sanghyun provided coverage on the upcoming...
306 Views
Sosei Placement - One-Year Return for Its 2015 Equity Raise Was 354%
Sosei Group Corp (4565 JP) is looking to raise US$204m by selling about 2m primary shares. Proceeds raised will be used to fund drug discovery and...
272 Views
Sosei Offering: Company History, Earnings Structure, Business Model and Use of Proceeds
On 10 Nov 2017 Sosei Group Corp (4565 JP) announced an overseas offering for 2.07m new shares (1.8m + 0.27m overallotment option). The offering...
225 Views
Mitsubishi Tanabe (4508) - Acquisition of NeuroDerm Playing to Strength, Not Weakness
The history of overseas acquisitions by Japanese drug companies is not a pretty one, as they've either overpaid for a skillset (Takeda (4502 JP)...
298 Views